Since NRG1 is expressed in the majority of HNSCC tumors, we asked whether ErbB3 itself is also expressed in HNSCC patient samples and thus, may serve as a tumor target for anticancer therapy. Here, ERBB3 is linked to head and neck squamous cell carcinoma.